SCHEMBL9048672

SCHEMBL9048672

Clc1ncnc(Cl)c1-c1ccc(-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
SRC P12931 1/20 0.41
ALDH1A1 P00352 4/20 0.41
ATM Q13315 1/20 0.39
ADK P55263 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAP4K4 O95819 1/20 0.39
SLC9A1 P19634 1/20 0.39
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
NFKB1 P19838 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3257778 0.95 PDE4A (0.46) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL16461405 0.85 LMNA (0.47) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL23042295 0.82 LCK (0.45) CYP1A2ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL4063214 0.81 MAPT (0.47) CYP1A2ALDH1A1ADKLMNASMN1; SMN2
SCHEMBL4840266 0.81 KDM4E (0.50) CYP1A2SRCADKNPSR1MAP4K4
SCHEMBL9045424 0.77 SMN1; SMN2 (0.50) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4065247 0.77 ADK (0.44) ALDH1A1ADKNPSR1TDP1LMNA
SCHEMBL999683 0.77 MAPT (0.50) CYP1A2PDE4APDE4BPDE4CPDE4D
SCHEMBL9046895 0.77 LMNA (0.51) CYP1A2LMNANPC1RAB9ASMN1; SMN2
SCHEMBL31626660 0.76 MEN1 (0.61) CYP1A2ALDH1A1ADKLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed